← All trials
NCT02922244
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2016
- Primary completion
- Apr 30, 2018
- Completion date
- Jun 30, 2018
- First posted
- Oct 4, 2016
- Last posted
- Jun 25, 2018
- Enrollment
- 150
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Chulabhorn Cancer CenterLead sponsor
- Chulabhorn Cancer CenterReponsible party - principal investigator
- Chulabhorn Cancer CenterSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.